Holistic Cancer Care Blog
Can dandelion help with gut cancer?
A natural breakthrough in cancer research has revealed that dandelion root can destroy up to 95 percent of cancer cells in just two days.
Scientists are now exploring how this common plant, long used in traditional medicine, may offer a safe and effective approach to combating certain types of cancer. Health Canada has approved Phase I clinical trials.
Laboratory studies show that compounds in dandelion root trigger cancer cell death without harming healthy cells. This selective action sets it apart from conventional chemotherapy, which often damages both healthy and diseased tissue.
Researchers are particularly excited about its potential against aggressive cancers that resist standard treatments. Beyond its cellular effects, dandelion root may also boost the immune system and reduce inflammation, further supporting the body’s natural defenses against cancer progression.
While clinical trials are still underway, early results suggest that this humble plant could become a powerful adjunct to modern oncology treatments. Experts caution that while promising, dandelion root should not replace prescribed treatments, but it highlights the untapped potential of nature’s own remedies.
Science is proving that sometimes the simplest plants may hold the most profound healing power.
These studies were primarily preclinical (laboratory and animal models) and have helped to validate the potential of dandelion root extract as a non-toxic anti-cancer alternative.
That warrants further investigation, with Health Canada having approved Phase I clinical trials for hematological cancers based on this research.
However, there have been no conclusive clinical studies on humans for gut cancer specifically.
Key Studies and Researchers
• University of Windsor and University of Ottawa Collaboration: A significant body of research on the topic was conducted by a team of Canadian researchers. Their 2016 study, published in Oncotarget, demonstrated that aqueous DRE selectively induces programmed cell death in human colon cancer cells (HT-29 and HCT116) without harming normal colon cells. o Lead Researchers: o Siyaram Pandey (Department of Chemistry & Biochemistry, University of Windsor) o Pamela Ovadje (Department of Chemistry & Biochemistry, University of Windsor) o John Thor Arnason (Department of Biology, University of Ottawa) • Later Research (2024): A more recent study published in Experimental and Therapeutic Medicine explored how DRE and taraxasterol (a key compound in dandelion) inhibit bacteria-driven colorectal cancer cell viability by blocking specific inflammatory pathways. o Lead Researchers: o K. Yang o Y. Wang#CancerCareBlog #CancerBreakthrough #NaturalHealing #HerbsMedicine #NaturalHealing
Enjoy your day
By the Holistic GoCancerGo Team